Skip to main content

ADVERTISEMENT

Jeff Craven

10/13/2018
Experts say concierge medicine reduces physician burnout and is better for patients. However, ethical and legal questions about transitioning a practice to a concierge model remain.
Experts say concierge medicine reduces physician burnout and is better for patients. However, ethical and legal questions about transitioning a practice to a concierge model remain.
Experts say concierge medicine...
10/13/2018
First Report Managed Care
Formulary Frontlines®
10/17/2019
With the advent of calcitonin gene-related peptide (CGRP) inhibitors, which are either monoclonal antibodies or CGRP receptor agonists that block CGRP proteins in the head and neck, another treatment option has emerged for patients where...
With the advent of calcitonin gene-related peptide (CGRP) inhibitors, which are either monoclonal antibodies or CGRP receptor agonists that block CGRP proteins in the head and neck, another treatment option has emerged for patients where...
With the advent of calcitonin...
10/17/2019
First Report Managed Care
03/31/2020
With more therapies than ever moving through the pipeline, developers and payers are looking at new ways to lower costs while ramping up gene therapy production.
With more therapies than ever moving through the pipeline, developers and payers are looking at new ways to lower costs while ramping up gene therapy production.
With more therapies than ever...
03/31/2020
First Report Managed Care
08/26/2019
Recent trials of GLP-1 receptor agonists and SGLT2 inhibitors have shown these drug classes could reduce or prevent cardiovascular and renal disease, improving outcomes despite their high cost.
Recent trials of GLP-1 receptor agonists and SGLT2 inhibitors have shown these drug classes could reduce or prevent cardiovascular and renal disease, improving outcomes despite their high cost.
Recent trials of GLP-1 receptor...
08/26/2019
First Report Managed Care
Literature Review
09/16/2021
In this literature review, we explore the data from the phase 3 VISION trial recently presented at the 2021 virtual annual meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine, examining...
In this literature review, we explore the data from the phase 3 VISION trial recently presented at the 2021 virtual annual meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine, examining...
In this literature review, we...
09/16/2021
First Report Managed Care
04/19/2019
Could medication with built-in digital sensors improve medication adherence and reduce health care costs? Experts discuss the potential benefits of novel digital medicines against privacy concerns of large-scale data collection.
Could medication with built-in digital sensors improve medication adherence and reduce health care costs? Experts discuss the potential benefits of novel digital medicines against privacy concerns of large-scale data collection.
Could medication with built-in...
04/19/2019
First Report Managed Care
Cover Story
04/18/2022
With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...
With the ever-rising costs of medications, new business models and patient care initiatives are becoming increasingly common methods to disrupt the industry to instill lasting change. But how do these recent ventures, like Mark Cuban’s new...
With the ever-rising costs of...
04/18/2022
First Report Managed Care
11/16/2018
Pharmaceutical companies are increasingly using big data techniques to improve outcomes, streamline the drug clinical pipeline and gain insight into new therapies. But real innovation may change how drug developers, payers, and providers...
Pharmaceutical companies are increasingly using big data techniques to improve outcomes, streamline the drug clinical pipeline and gain insight into new therapies. But real innovation may change how drug developers, payers, and providers...
Pharmaceutical companies are...
11/16/2018
First Report Managed Care
09/18/2018
Studies have shown success with hepatitis C-positive kidney transplantation in patients with end-stage renal disease followed by treatment with direct-acting antivirals to cure the infection. Experts discuss why this approach is not only...
Studies have shown success with hepatitis C-positive kidney transplantation in patients with end-stage renal disease followed by treatment with direct-acting antivirals to cure the infection. Experts discuss why this approach is not only...
Studies have shown success with...
09/18/2018
First Report Managed Care
08/30/2018
Gene therapy is a transformational treatment for some patients to potentially cure or prevent rare diseases. But questions still remain about how these drugs should be priced and who will pay for them.
Gene therapy is a transformational treatment for some patients to potentially cure or prevent rare diseases. But questions still remain about how these drugs should be priced and who will pay for them.
Gene therapy is a...
08/30/2018
First Report Managed Care